Case Presentation: Immunotherapy is an emerging therapeutic option in the field of oncology. Dermatological toxicities are the most prevalent immune-related adverse events associated with immunotherapy. Herein, we report a case of a 60-year-old male who developed localized bullous pemphigoid after nearly a year of treatment with a PD-1 inhibitor, nivolumab, for metastatic renal cell carcinoma. [...]

Case Presentation: An 80-year old woman with a PMH of a hemorrhagic R thalamic CVA, CKD3, HTN, HLD, T2DM presents for weakness and fevers in the setting of a 1 month long diffuse rash. The rash began on her legs, but spread to gluteal region, chest, arms, and palms/soles. The lesions started as blisters that [...]

Case Presentation: Our patient is a 66-year-old man, a former 100-pack year smoker, with a history of hypertension, gastroesophageal reflux, emphysema, who was diagnosed in September of 2019 with stage IV squamous cell lung cancer (PD-L1 0%). He was initiated on concurrent radiation with carboplatin and nab-paclitaxel. He had a partial response to this treatment [...]

Case Presentation: 70-year-old female with ILD and bullous pemphigoid (BP) on mycophenolate mofetil and prednisone initially presented to emergency room for hematuria and chills, where she was found to have elevated creatinine of 1.25 mg/dL (baseline creatinine 0.4 mg/dL) and prescribed a course of ciprofloxacin for hemorrhagic cystitis. She was admitted three days later due [...]

Case Presentation: A 76-year-old man with history of diabetes mellitus, atrial fibrillation, colonic adenoma, and recent self-reported bed bug infestation presents with one month of pruritic rash. On interview, he also endorses progressive edema, dyspnea on exertion, orthopnea, as well as 5 days of melena. Admission exam is notable for anasarca and diffuse, tense fluid-filled [...]